Show simple item record

dc.contributor.authorWorld Health Organization
dc.coverage.spatialGenevaen_US
dc.date.accessioned2017-08-10T16:17:17Z
dc.date.available2017-08-10T16:17:17Z
dc.date.issued2017
dc.identifier.govdocWHO/IVB/17.09
dc.identifier.urihttps://iris.who.int/handle/10665/258703
dc.description17 p.en_US
dc.language.isoenen_US
dc.publisherWorld Health Organizationen_US
dc.rightsCC BY-NC-SA 3.0 IGOen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/3.0/igoen_US
dc.subject.meshStreptococcus agalactiaeen_US
dc.subject.meshVaccinesen_US
dc.subject.meshInfanten_US
dc.titleWHO preferred product characteristics for group B streptococcus vaccinesen_US
dc.typeTechnical documentsen_US
dc.rights.holderWorld Health Organizationen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record